Save Recarbrio as a Last Resort for Resistant Infections

February 2020

Recarbrio (reh-CAR-bree-oh, imipenem/cilastatin/relebactam) is a new combo antibiotic for resistant gram-negative infections...

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diuretics Know Rules of Thumb to Manage Loop Diuretics
Med Administration Evaluate Whether to Redose Meds After Vomiting
Acne Don’t Jump to Aklief or Amzeeq for Acne
Contraceptives Dispel Concerns About Continuous Contraception
Hepatitis C Expand Screening and Treatment for Hep C in Your Practice
Nutrition Answer Questions About Plant-Based, Non-Dairy Milks
Med Safety Recommend Eye Exams for Patients on Elmiron
Parkinson's Disease Save Nourianz as a Last Resort for Parkinson’s
Med Administration Educate Patients on Ways to Improve the Taste of Meds
Cystic Fibrosis Expect Trikafta to Be a Game Changer for Cystic Fibrosis
Cardiology Be Alert for Colchicine Uses Other Than Gout
Seizures Consider Levetiracetam for Benzo-Resistant Status Epilepticus
New Drugs Save Recarbrio as a Last Resort for Resistant Infections